ACON_OUT_1 [2025-04-02 13:33:24 -0400] 2542 Bytes | 674 tokens | Cum: 674 tkns (8.43% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 1:33:23 PM on Wed Apr 02, 2025 -0400, and I'm firing up the spotlight on Aclarion (ACON), moving from 11.31 to 13.25. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

--- COMPANY PROFILE ---
Company: Aclarion (ACON)
IPO: 2022-04-22 (2 Years Ago)
Market Cap: $5,653,934
Shares Outstanding: 580,000
Industry: SERVICES-MEDICAL LABORATORIES
Exchange: XNAS
Description: Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Here's the first list of news for Aclarion:

C1 - Today 06:00AM - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
C2 - Mar-31-25 07:00AM - Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
C3 - Mar-26-25 07:00AM - Aclarion Announces Reverse Stock Split
C4 - Mar-13-25 09:25AM - Aclarion Provides Shareholder Update
C5 - Mar-07-25 09:45AM - Aclarion announces expansion plans with RadNet affiliates in NY, NJ
C6 - Mar-06-25 09:35AM - Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
C7 - Mar-03-25 06:00AM - Aclarion Announces First Commercial Agreement with Scripps Health
C8 - Feb-28-25 04:01PM - Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Aclarion (ACON)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

ACON_OUT_3 [2025-04-02 13:33:28 -0400] 1106 Bytes | 314 tokens | Cum: 990 tkns (12.38% of 8k)
==========================================================================

Showing C1 (chunk 1 of 6): C1:
**Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California**
Date: Today 06:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/04/02/3054055/0/en/Aclarion-Announces-Expansion-to-Santa-Monica-with-Medical-Imaging-Center-of-Southern-California.html

April 02, 2025 06:00 ET| Source:Aclarion, Inc.Aclarion, Inc.

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services

MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica

BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

ACON_OUT_5 [2025-04-02 13:33:29 -0400] 1029 Bytes | 279 tokens | Cum: 1351 tkns (16.89% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-02T10:35:36Z - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California | Ta...
A2 - 2025-04-02T10:10:49Z - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California...
A3 - 2025-04-02T10:00:00Z - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - Ac...
A4 - 2025-04-02T10:09:00Z - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California...
A5 - 2025-04-01T22:43:59Z - EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro -- Where Do Tesla, Nvidia, Apple, Appl...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ACON_OUT_7 [2025-04-02 13:33:34 -0400] 1098 Bytes | 302 tokens | Cum: 1655 tkns (20.69% of 8k)
==========================================================================

Showing A1 (chunk 1 of 7): A1:
**Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California | Taiwan News | Apr. 2, 2025 18:00**Date: 2025-04-02Source: {'uri': 'taiwannews.com.tw', 'dataType': 'news', 'title': 'Taiwan News'}URL: https://taiwannews.com.tw/en/news/6075623MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services

MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica

BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

ACON_OUT_9 [2025-04-02 13:33:35 -0400] 973 Bytes | 295 tokens | Cum: 2045 tkns (25.56% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-03T11:00:00Z - Aclarion Announces First Commercial Agreement with Scripps Health
B2 - 2025-02-28T21:01:00Z - Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
B3 - 2025-02-20T11:00:00Z - Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
B4 - 2025-02-11T12:58:00Z - Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
B5 - 2024-10-10T11:00:00Z - Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
B6 - 2024-09-12T10:57:00Z - Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ACON_OUT_11 [2025-04-02 13:33:39 -0400] 721 Bytes | 197 tokens | Cum: 2244 tkns (28.05% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Aclarion Announces First Commercial Agreement with Scripps Health**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/03/3035378/0/en/Aclarion-Announces-First-Commercial-Agreement-with-Scripps-Health.htmlAclarion, a healthcare technology company, has established a commercial agreement with Scripps Health in San Diego to bring its Nociscan technology to the region. Nociscan uses MR Spectroscopy and AI to help physicians identify the location of chronic low back pain.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

ACON_OUT_13 [2025-04-02 13:33:40 -0400] 1141 Bytes | 300 tokens | Cum: 2616 tkns (32.70% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-28 8-K Item 9.01 Fin Stmnts and Exhibits.

(d) Exhibits

Exhibit

Number

Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company dated March 26, 2025 104 Cover Page Interactive Data File - the cover page iXBRL tags...

S2 - 2025-02-28 8-K Item 7.01. Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release announcing the convening and adjournment of the Special Meeting and the information for the reconvened Special Meeting. A copy of the press release is furnished as Exhibit 99.1 to this...

S3 - 2025-02-28 8-K Item 7.01. Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release announcing the convening and adjournment of the Special Meeting and the information for the reconvened Special Meeting. A copy of the press release is furnished as Exhibit 99.1 to this...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ACON_OUT_15 [2025-04-02 13:33:48 -0400] 537 Bytes | 152 tokens | Cum: 2770 tkns (34.62% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Number

Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company dated March 26, 2025 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document

2...

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

ACON_OUT_17 [2025-04-02 13:34:00 -0400] 4210 Bytes | 1188 tokens | Cum: 4132 tkns (51.65% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+-------------------------+
| Volume: 97,853 | Perf Month: -91.63% | Option/Short: No / Yes | Sales Y/Y TTM: -41.41% |
+---------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 205.01K | Perf Quarter: -99.01% | Short Float: 0.78% | ROE: -745.47% |
+---------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 0.79 | Index: - | Short Ratio: 0.02 | ROI: -250.25% |
+---------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 34.11 | Market Cap: 7.56M | Short Interest: 0.00M | Sales Surprise: -20.00% |
+---------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 23.38 | Shs Outstand: - | Beta: 1.06 | EPS Surprise: 3.23% |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA20: -38.70% | Shs Float: 0.58M | Sales Q/Q: -24.43% | P/E: - |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA50: -89.15% | Inst Own: 0.13% | Sales past 5Y: - | Earnings: Feb 26 |
+---------------------+-----------------------+------------------------+-------------------------+
| SMA200: -99.09% | Insider Own: 0.00% | Employees: - | |
+---------------------+-----------------------+------------------------+-------------------------+
| Perf Week: -16.26% | Insider Trans: - | Debt/Eq: 0.00 | |
+---------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 14407, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -1378318.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 12.88
Average Volume: 487617.52
30-Day High: 205.2
30-Day Low: 10.8

[Detailed Financials: Q3 2024]
- Total Assets: $3,188,052.0
- Total Liabilities: $678,267
- Total Equity: $2,509,785.0
- Current Assets: $1,897,321.0
- Current Liabilities: $678,267

[Income Statement: Q3 2024]
- Revenue: $14,407.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.15

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $139,410

[Detailed Financials: Q2 2024]
- Total Assets: $3,088,821.0
- Total Liabilities: $1,446,644.0
- Total Equity: $1,642,177.0
- Current Assets: $1,851,757.0
- Current Liabilities: $1,446,644.0

[Income Statement: Q2 2024]
- Revenue: $10,971.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.15

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-959,948
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

ACON_OUT_19 [2025-04-02 13:34:02 -0400] 676 Bytes | 167 tokens | Cum: 4605 tkns (57.56% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ACON_IN_21 [2025-04-02 13:34:02 -0400] 126 Bytes | 29 tokens | Cum: 4662 tkns (58.27% of 8k)
==========================================================================

====================================
[2025-04-02 13:34:02] # Analysis Completed
Elapsed Time: 39.00 seconds